Quality of life and disease severity in patients with atopic dermatitis

Journal of the European Academy of Dermatology and Venereology

Volumn 30, Issue 10, 2016, Pages 1760-1767

  Holm, J G ^a   Agner, T ^a   Clausen, M L ^a   Thomsen, S F ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FILAGGRIN;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CHILD; COHORT ANALYSIS; CONTACT SENSITIZATION; DANISH CITIZEN; DERMATOLOGY LIFE QUALITY INDEX; DISEASE ASSOCIATION; DISEASE SEVERITY; DISEASE SEVERITY ASSESSMENT; ECZEMA; EOSINOPHIL COUNT; FACIAL ECZEMA; FEMALE; FILAGGRIN GENE; FOOT ECZEMA; GENE MUTATION; HAND ECZEMA; HUMAN; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; POLLEN ALLERGY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SCORING OF ATOPIC DERMATITIS DISEASE SEVERITY SCORE; SEX DIFFERENCE; SMOKING; PATHOPHYSIOLOGY; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FEMALE; HUMANS; MALE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 84991660756     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.13689     Document Type: Article

References (43)

1. Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract 2006; 60: 984–992.
2. Carroll CL, Balkrishnan R, Feldman SR, Fleischer AB, Manuel JC. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol 2005; 22: 192–199.
3. Chamlin SL, Frieden IJ, Williams ML, Chren M-M. Effects of atopic dermatitis on young American children and their families. Pediatrics 2004; 114: 607–611.
4. Camfferman D, Kennedy JD, Gold M, Martin AJ, Lushington K. Eczema and sleep and its relationship to daytime functioning in children. Sleep Med Rev 2010; 14: 359–369.
5. Abramovits W. Atopic dermatitis. J Am Acad Dermatol 2005; 53: 86–93.
6. Kim DH, Li K, Seo SJ et al. Quality of life and disease severity are correlated in patients with atopic dermatitis. J Korean Med Sci 2012; 27: 1327–1332.
7. Pustišek N, Vurnek Živković M, Šitum M. Quality of life in families with children with atopic dermatitis. Pediatr Dermatol 2016; 33: 28–32.
8. Chernyshov P, Jirakova A, Ho R et al. An international multicenter study on quality of life and family quality of life in children with atopic dermatitis. Indian J Dermatol Venereol Leprol 2013; 79: 52.
9. Boccardi D, D'Auria E, Turati F et al. Disease severity and quality of life in children with atopic dermatitis. Minerva Pediatr 2015. [Epub ahead of print].
10. Ražnatović Djurović M, Janković J, Tomić Spirić V, Janković S. Health-related quality of life in children with moderate to severe atopic dermatitis. Acta Dermatovenerol Croat 2015; 23: 178–184.
11. Francis Thomsen S. The danish atopy database (DAD): rationale and methods. Open Allergy J 2012; 5: 62–64.
12. Hanifin J, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermatovener 1980; 92: 44–47.
13. Wards K. Clinical and laboratory investigations european task force on atopic dermatitis atopic dermatitis eczema scoring composite index severity. Dermatology 1993; 186: 23–31.
14. Rajka G, Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1989; 144: 13–14.
15. Rehal B, Armstrong A. Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985–2010. PLoS ONE 2011; 6: e17520.
16. Chalmers J, Deckert S, Schmitt J. Reaching clinically relevant outcome measures for new pharmacotherapy and immunotherapy of atopic eczema. Curr Opin Allergy Clin Immunol 2015; 15: 227–233.
17. Zachariae R, Zachariae C, Ibsen H, Touborg Mortensen J, Christian Wulf H. Dermatology life quality index: data from Danish inpatients and outpatients. Acta Derm Venereol 2000; 80: 272–276.
18. Lewis-Jones MS, Finlay AY. The Children's dermatology life quality index (CDLQI): initial validation and practical use. Br J Dermatol 1995; 132: 942–949.
19. Eriksen L, Curtis T, Grønbæk M, Helge JW, Tolstrup JS. The association between physical activity, cardiorespiratory fitness and self-rated health. Prev Med (Baltim) 2013; 57: 900–902.
20. Darsow U, Wollenberg A, Simon D et al. ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2010; 24: 317–328.
21. Lewis V, Finlay AY. 10 years experience of the dermatology life quality index (DLQI). J Investig Dermatol Symp Proc 2004; 9: 169–180.
22. Finlay AY, Khan GK. Dermatology life quality index (DLQI)–a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210–216.
23. Badia X, Mascaró JM, Lozano R. Reaching clinically relevant outcome measures for new pharmacotherapy and immunotherapy of atopic eczema. Curr Opin Allergy Clin Immunol. 2015 June; 15: 227-233.
24. Linnet J, Jemec GB. An assessment of anxiety and dermatology life quality in patients with atopic dermatitis. Br J Dermatol 1999; 140: 268–272.
25. Holm EA, Wulf HC, Stegmann H, Jemec GBE. Life quality assessment among patients with atopic eczema. Br J Dermatol 2006; 154: 719–725.
26. Chuh AAT, Chan HHL. Effect on quality of life in patients with pityriasis rosea: is it associated with rash severity?. Int J Dermatol 2005; 44: 372–377.
27. Sheinkopf LE, Rafi AW, Do LAT, Katz RM, Klaustermeyer WB. Efficacy of omalizumab in the treatment of atopic dermatitis: a pilot study. Allergy Asthma Proc 2008; 29: 530–537.
28. Lee HJ, Park CO, Lee JHLK. Life quality assessment among adult patients with atopic dermatitis. Korean J Dermatol 2007; 45: 159–164.
29. Ben-Gashir MA, Seed PT, Hay RJ. Quality of life and disease severity are correlated in children with atopic dermatitis. Br J Dermatol 2004; 150: 284–290.
30. Haeck IM, ten Berge O, van Velsen SG, de Bruin-Weller MS, Bruijnzeel-Koomen CA, Knol MJ. Moderate correlation between quality of life and disease activity in adult patients with atopic dermatitis. J Eur Acad Dermatol Venereol 2012; 26: 236–241.
31. Taïeb A, Boralevi F, Seneschal J et al. Atopic Dermatitis Burden Scale for adults: development and validation of a new assessment tool. Acta Derm Venereol 2015; 95: 700–705.
32. Van Oosterhout M, Janmohamed SR, Spierings M, Hiddinga J, de Waard-van der Spek FB, Oranje AP. Correlation between Objective SCORAD and Three-Item Severity Score used by physicians and Objective PO-SCORAD used by parents/patients in children with atopic dermatitis. Dermatology 2015; 230: 105–112.
33. Baron SE, Morris PK, Dye L, Fielding D, Goulden V. The effect of dermatology consultations in secondary care on treatment outcome and quality of life in new adult patients with atopic dermatitis. British Journal of Dermatology 2006; 154: 942–949.
34. Yano C, Saeki H, Ishiji T et al. Impact of disease severity on work productivity and activity impairment in Japanese patients with atopic dermatitis. J Dermatol 2013; 40: 736–739.
35. Gånemo A, Svensson Å, Lindberg M, Wahlgren C. Quality of life in Swedish children with eczema. Acta Derm Venereol 2007; 87: 345–349.
36. Yano C, Saeki H, Ishiji T et al. Impact of disease severity on sleep quality in Japanese patients with atopic dermatitis. J Dermatol Sci 2013; 72: 195–197.
37. Misery L, Finlay AY, Martin N et al. Atopic dermatitis: impact on the quality of life of patients and their partners. Dermatology 2007; 215: 123–129.
38. Ballardini N, Kull I, Söderhäll C, Lilja G, Wickman M, Wahlgren CF. Eczema severity in preadolescent children and its relation to sex, filaggrin mutations, asthma, rhinitis, aggravating factors and topical treatment: a report from the BAMSE birth cohort. Br J Dermatol 2013; 168: 588–594.
39. Kabashima K. New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity. J Dermatol Sci 2013; 70: 3–11.
40. Rodríguez E, Baurecht H, Herberich E et al. Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol 2009; 123: 1361–1370.e7.
41. Palmer CN, Irvine AD, Terron-Kwiatkowski A et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38: 441–446.
42. Irvine AD, McLean WHI, Leung DYM. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011; 365: 1315–1327.
43. Ching GK, Hon K-L, Ng P-C, Leung T-F. Filaggrin null mutations in childhood atopic dermatitis among the Chinese. Int J Immunogenet 2009; 36: 251–254.